Published data on vitamin D and the quality of life of asthma patients are scarce and disparate. The ACVID clinical trial, published in 2020, showed the efficacy of calcifediol in improving asthma ...control in asthma patients with vitamin D deficiency. Data on vitamin D and quality of life measured by the Mini-AQLQ questionnaire were analysed: supplemented patients showed improved quality of life compared with a placebo group, and the initial mini-AQLQ scores were improved for both groups.
•Calcifediol supplementation improved quality of life in asthmatics patients.•A positive correlation was observed between vitamin D levels and quality of life.•Calcifediol improves symptoms, activity limitation and emotional sphere in asthma.
Red wine pomace products (WPP) have antimicrobial activities against human pathogens, and it was suggested that they have a probable anti-Listeria effect. This manuscript evaluates the intestinal ...cell monolayer invasive capacity of Listeria monocytogenes strains obtained from human, salmon, cheese, and L. innocua treated with two WPP (WPP-N and WPP-C) of different polyphenol contents using Caco-2 and SW480 cells. The invasion was dependent of the cell line, being higher in the SW480 than in the Caco-2 cell line. Human and salmon L. monocytogenes strains caused cell invasion in both cell lines, while cheese and L. innocua did not cause an invasion. The phenolic contents of WPP-N are characterized by high levels of anthocyanin and stilbenes and WPP-C by a high content of phenolic acids. The inhibitory effect of the WPPs was dependent of the strain and of the degree of differentiation of the intestinal cells line. The inhibition of Listeria invasion by WPPs in the SW480 cell line, especially with WPP-C, were higher than the Caco-2 cell line inhibited mainly by WPP-N. This effect is associated with the WPPs’ ability to protect the integrity of the intestinal barrier by modification of the cell–cell junction protein expression. The gene expression of E-cadherin and occludin are involved in the L. monocytogenes invasion of both the Caco-2 and SW480 cell lines, while the gene expression of claudin is only involved in the invasion of SW480. These findings suggest that WPPs have an inhibitory L. monocytogenes invasion effect in gastrointestinal cells lines.
Type 2 diabetes mellitus and depression are highly prevalent diseases that are associated with an increased risk of cardiovascular disease and mortality. There is evidence about a bidirectional ...association between depressive symptoms and type 2 diabetes mellitus. However, prognostic implications of the joint effects of these two diseases on cardiovascular morbidity and mortality are not well-known.
A three-year, observational, prospective, cohort study, carried out in Primary Health Care Centres in Madrid (Spain). The project aims to analyze the effect of depression on cardiovascular events, all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus, and to estimate a clinical predictive model of depression in these patients.The number of patients required is 3255, all them with type 2 diabetes mellitus, older than 18 years, who regularly visit their Primary Health Care Centres and agree to participate. They are chosen by simple random sampling from the list of patients with type 2 diabetes mellitus of each general practitioner.The main outcome measures are all-cause and cardiovascular mortality and cardiovascular morbidity; and exposure variable is the major depressive disorder.There will be a comparison between depressed and not depressed patients in all-cause mortality, cardiovascular mortality, coronary artery disease and stroke using the Chi-squared test. Logistic regression with random effects will be used to adjust for prognostic factors. Confounding factors that might alter the effect recorded will be taken into account in this analysis. To assess the effect of depression on the mortality, a survival analysis will be used comparing the two groups using the log-rank test. The control of potential confounding variables will be performed by the construction of a Cox regression model.
Our study's main contribution is to evaluate the increase in the risk of cardiovascular morbidity and mortality, in depressed Spanish adults with type 2 diabetes mellitus attended in Primary Health Care Setting. It would also be useful to identify subgroups of patients for which the interventions could be more beneficial.
Celotno besedilo
Dostopno za:
DOBA, IZUM, KILJ, NUK, PILJ, PNG, SAZU, SIK, UILJ, UKNU, UL, UM, UPUK
To describe the prevalence of Peripheral Artery Disease (PAD) in a random population sample and to evaluate its relationship with Mediterranean diet and with other potential cardiovascular risk ...factors such as serum uric acid and pulse pressure in individuals ranged 45 to 74 years.
Cross-sectional analysis of 1568 subjects (mean age 6.5 years, 43% males), randomly selected from the population. A fasting blood sample was obtained to determine glucose, lipids, and HbA1C levels. An oral glucose tolerance test was performed in non-diabetic subjects. PAD was evaluated by ankle-brachial index and/or having a prior diagnosis.
PAD prevalence was 3.81% (95% CI, 2.97-4.87) for all participants. In men, PAD prevalence was significantly higher than in women 5.17% (95% CI, 3.74-7.11) vs. 2.78% (95% CI, 1.89-4.07); p = 0.014. Serum uric acid in the upper quartile was associated with the highest odds ratio (OR) of PAD (for uric acid > 6.1 mg/dl, OR = 4.31; 95% CI, 1.49-12.44). The remaining variables more strongly associated with PAD were: Heart rate >90 bpm (OR = 4.16; 95%CI, 1.62-10.65), pulse pressure in the upper quartile (≥ 54 mmHg) (OR = 3.82; 95%CI, 1.50-9.71), adherence to Mediterranean diet (OR = 2.73; 95% CI, 1.48-5.04), and former smoker status (OR = 2.04; 95%CI, 1.00-4.16).
Our results show the existence of a low prevalence of peripheral artery disease in a population aged 45-74 years. Serum uric acid, pulse pressure and heart rate >90 bpm were strongly associated with peripheral artery disease. The direct association between Mediterranean diet and peripheral artery disease that we have found should be evaluated through a follow-up study under clinical practice conditions.
Celotno besedilo
Dostopno za:
DOBA, IZUM, KILJ, NUK, PILJ, PNG, SAZU, SIK, UILJ, UKNU, UL, UM, UPUK
To evaluate the performance of the Finnish Diabetes Risk Score (FINDRISC) and a simplified FINDRISC score (MADRISC) in screening for undiagnosed type 2 diabetes mellitus (UT2DM) and dysglycaemia.
A ...population-based, cross-sectional, descriptive study was carried out with participants with UT2DM, ranged between 45-74 years and lived in two districts in the north of metropolitan Madrid (Spain). The FINDRISC and MADRISC scores were evaluated using the area under the receiver operating characteristic curve method (ROC-AUC). Four different gold standards were used for UT2DM and any dysglycaemia, as follows: fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), HbA1c, and OGTT or HbA1c. Dysglycaemia and UT2DM were defined according to American Diabetes Association criteria.
The study population comprised 1,426 participants (832 females and 594 males) with a mean age of 62 years (SD = 6.1). When HbA1c or OGTT criteria were used, the prevalence of UT2DM was 7.4% (10.4% in men and 5.2% in women; p<0.01) and the FINDRISC ROC-AUC for UT2DM was 0.72 (95% CI, 0.69-0.74). The optimal cut-off point was ≥13 (sensitivity = 63.8%, specificity = 65.1%). The ROC-AUC of MADRISC was 0.76 (95% CI, 0.72-0.81) with ≥13 as the optimal cut-off point (sensitivity = 84.8%, specificity = 54.6%). FINDRISC score ≥12 for detecting any dysglycaemia offered the best cut-off point when HbA1c alone or OGTT and HbA1c were the criteria used.
FINDRISC proved to be a useful instrument in screening for dysglycaemia and UT2DM. In the screening of UT2DM, the simplified MADRISC performed as well as FINDRISC.
Celotno besedilo
Dostopno za:
DOBA, IZUM, KILJ, NUK, PILJ, PNG, SAZU, SIK, UILJ, UKNU, UL, UM, UPUK
The aim of the study was to analyze the relationship between anthropometry, training characteristics, muscular strength and effort-related cardiovascular response and marathon race time in male ...amateur runners.
A total of 84 male amateur marathon runners aged between 23 and 70 years took part in this study (41.0±9.5 years). All of them competed in the 2013 edition of the Madrid Marathon with a finish time between 169.8 and 316 minutes (226.0±28.5 minutes). Age, running experience, number of marathon races finished, mean kilometers run weekly in the last three months, and previous personal best time in the 10 km, half marathon and marathon were recorded. Moreover, anthropometric characteristics, and the results from the Ruffier Test and a whole-body isometric force test were measured. After the marathon, the race time was registered.
Training volume (r=-0.479; P=0.001), previous running milestones (marathon r=0.756; half-marathon r=0.812; 10-km r=0.732; P<0.001), cardiovascular fitness (r=0.371; P=0.001) and anthropometric variables (body mass, Body Mass Index, body fat percentage, skinfolds and lower leg volume) were correlated to marathon performance (P<0.05). Two regression models appeared from the data with r2>0.50. The best, including body fat percentage, heart rate change during the recovery after the Ruffier Test and the half-marathon race time, was strongly correlated with real marathon performance (r=0.77; P<0.001). A second regression model was proposed replacing the half-marathon performance with the 10-km race time, reducing the correlation to 0.73 (P<0.001).
Marathon performance could be partially predicted by two different equations, including body fat percentage, recovery heart rate in the Ruffier Test and a half-marathon or 10-km performance.
The purpose of this study was to analyze the relationship between marathon race time and expiratory pulmonary parameters in a heterogeneous group of amateur marathoners.
A total of 110 marathon ...runners (age=41.9±9.4 yr, body mass=74.0±9.1 kg, height=175.0±8.0 cm) volunteered to participate in this study. First, they completed a questionnaire about running experience and best performance time in the 10-km, half-marathon and marathon competitions. Then, they performed a maximal spirometry test following guidelines for standardized spirometry. Measurement included peak expiratory flow (PEF), forced expiratory volume in the first second (FEV1) and forced vital capacity (FVC). All these expiratory variables were normalized for the participant's body mass. Within 3 days of the spirometry test, participants competed in an official marathon and race time was measured by a chip-timing. After this, participants were grouped by their marathon race time as follows: <210 min, N.=33; between 210 and 240 min, N.=31; and >240 min, N.=46).
Marathon race time correlated to the FVC·kg-1 (r=-0.41; P<0.001), to FEV1·kg-1 (r=-0.40; P<0.001), and PEF·kg-1 (r=-0.50; P=0.005). However, self-reported running experience did not show significant correlations to FVC·kg-1 and PEF·kg-1 (P>0.05). The group of faster marathoners (e.g., <210 min) had greater FEV1·kg-1 (<210 min group: 0.064±0.009; 210-240 min group: 0.058±0.008; >240 min group: 0.057±0.009; P<0.001) and higher FVC·kg-1 (<210 min group: 0.081±0.011; 210-240 min group: 0.075±0.012; >240 min group: 0.072±0.010; P<0.001) than the other two groups of slower runners.
These results suggest a significant relationship between individual pulmonary function and marathon race time. Thus, a higher lung capacity per kg of body mass might be a key variable for marathon performance in amateur runners.
Aim To describe the prevalence of Peripheral Artery Disease (PAD) in a random population sample and to evaluate its relationship with Mediterranean diet and with other potential cardiovascular risk ...factors such as serum uric acid and pulse pressure in individuals ranged 45 to 74 years. Methods Cross-sectional analysis of 1568 subjects (mean age 6.5 years, 43% males), randomly selected from the population. A fasting blood sample was obtained to determine glucose, lipids, and HbA1C levels. An oral glucose tolerance test was performed in non-diabetic subjects. PAD was evaluated by ankle-brachial index and/or having a prior diagnosis. Results PAD prevalence was 3.81% (95% CI, 2.97-4.87) for all participants. In men, PAD prevalence was significantly higher than in women 5.17% (95% CI, 3.74-7.11) vs. 2.78% (95% CI, 1.89-4.07); p = 0.014. Serum uric acid in the upper quartile was associated with the highest odds ratio (OR) of PAD (for uric acid > 6.1 mg/dl, OR = 4.31; 95% CI, 1.49-12.44). The remaining variables more strongly associated with PAD were: Heart rate >90 bpm (OR = 4.16; 95%CI, 1.62-10.65), pulse pressure in the upper quartile (greater than or equal to 54 mmHg) (OR = 3.82; 95%CI, 1.50-9.71), adherence to Mediterranean diet (OR = 2.73; 95% CI, 1.48-5.04), and former smoker status (OR = 2.04; 95%CI, 1.00-4.16). Conclusions Our results show the existence of a low prevalence of peripheral artery disease in a population aged 45-74 years. Serum uric acid, pulse pressure and heart rate >90 bpm were strongly associated with peripheral artery disease. The direct association between Mediterranean diet and peripheral artery disease that we have found should be evaluated through a follow-up study under clinical practice conditions.
Celotno besedilo
Dostopno za:
DOBA, IZUM, KILJ, NUK, PILJ, PNG, SAZU, SIK, UILJ, UKNU, UL, UM, UPUK
Resumen Introducción y objetivos El retraso diagnóstico de la hipertensión arterial puede favorecer un control deficiente y el incremento del riesgo cardiovascular. El objetivo es estimar el retraso ...diagnóstico de la hipertensión en lo diabéticos tipo 2 y la probabilidad de que se los diagnostique en un plazo adecuado (primeros 6 meses) y analizar las características de pacientes y médicos asociadas al retraso diagnóstico. Métodos Cohorte dinámica retrospectiva, con 7 años de seguimiento en atención primaria, de 8.074 adultos diabéticos a los que se incluyó en el momento de cumplir criterios diagnósticos de hipertensión arterial considerando dos umbrales: 140/90 y 130/80 mmHg. Se estimó el tiempo transcurrido desde el cumplimiento de dichos criterios hasta el registro del diagnóstico la evolución temporal de la probabilidad de que no se diagnosticara mediante análisis de supervivencia de Kaplan-Meier y las variables asociadas al diagnóstico adecuado mediante regresión logística. Resultados El retraso diagnóstico medio fue 8,9 ± 15,4 meses para pacientes que acudieron con presión arterial ≥ 140/90 mmHg frente a los 15,2 ± 19,6 meses de aquellos con presión < 140/90 mmHg (p < 0,001). Las principales variables asociadas al diagnóstico adecuado fueron presión arterial inicial ≥ 140/90 mmHg ( odds ratio = 2,77; intervalo de confianza del 95%, 2,44-3,15), no tener infarto agudo de miocardio previo ( odds ratio = 2,23; intervalo de confianza del 95%, 1,67-2,99), obesidad ( odds ratio = 1,70; intervalo de confianza del 95%, 1,44-1,99), no sufrir depresión ( odds ratio = 1,63; intervalo de confianza del 95%, 1,27-2,08), ser mujer ( odds ratio = 1,29; intervalo de confianza del 95%, 1,14-1,46), tener más edad o tratamiento antidiabético más intensivo. La edad del médico mostró relación inversa y su estabilidad laboral, relación directa. Conclusiones El retraso diagnóstico medio de la hipertensión en diabéticos fue > 6 meses y varió según el umbral diagnóstico utilizado. Los pacientes con presión arterial inicial ≥ 140/90 mmHg presentaron mayor probabilidad de diagnóstico adecuado.
PDF
